Using smart insulin pens to improve diabetes management in dependent patients
Official title: Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
Run by Centre Hospitalier Sud Francilien · NCT06192940 · Data updated 2026-11-12
This study is testing if smart insulin pens and continuous glucose monitors can help caregivers manage diabetes better for patients in nursing homes and reduce problems like low blood sugar.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Centre Hospitalier Sud Francilien Academic / other |
| Locations | 1 site (Corbeil-Essonnes, France) |
| Status | Recruiting |
| Started | March 28, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | March 14, 2025 |
| Trial ID | NCT06192940 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with type 1 or type 2 diabetes who require multiple insulin injections and are dependent on health professionals for their treatment.
✕Probably not a fit
Patients who are not dependent on caregivers for insulin management or those who refuse to participate in the study may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess how smart connected insulin pens and continuous glucose monitoring can enhance insulin therapy for dependent or institutionalized patients with diabetes. It focuses on identifying and addressing the misuse of insulin therapy by caregivers, particularly in nursing homes where hypoglycemia is prevalent. By equipping patients with continuous glucose measurement systems and connected pens, the study seeks to provide insights into improving glycemic control and reducing hospitalizations due to insulin mismanagement.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and diabetes management for dependent patients.
How similar studies have gone: Previous studies have shown that smart connected insulin pens can improve insulin management in type 1 diabetes, suggesting potential success for this approach in dependent patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Older than 18 years patient with type 1 or 2 diabetes * Treated with multiple insulin injections * Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before * Dependent on a health professional for treatment management. * Subject informed of the study and not objecting to data collection. Exclusion Criteria: \- Patient refusing study.
Where it's running
-
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France Recruiting
Study contacts
- Principal investigator: Marie BOULY, APN — Centre Hospitalier Sud Francilien
- Study coordinator: Marie BOULY, APN
- Email: marie.bouly@chsf.fr
- Phone: 01 61 69 35 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.